Fate Therapeutics Appoints Wen Bo Wang, Ph.D. as Senior Vice President, Technical Operations
SAN DIEGO, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that Wen Bo Wang, Ph.D., a …